ORCL
68
3
EMC
85
38
XOM
54
3
AZO
45
2
BK
74
3
CHK
39
19
KR
59
10
SLB
46
2
AVY
77
2
MDLZ
46
-4
NUE
40
-3
MAC
71
-4
AIV
62
-2
JPM
71
2
NRG
72
-2
HBI
62
7
SIG
79
-2
HST
39
-5
RCL
62
-3
DRI
63
3
ORCL
68
3
EMC
85
38
XOM
54
3
AZO
45
2
BK
74
3
CHK
39
19
KR
59
10
SLB
46
2
AVY
77
2
MDLZ
46
-4
NUE
40
-3
MAC
71
-4
AIV
62
-2
JPM
71
2
NRG
72
-2
HBI
62
7
SIG
79
-2
HST
39
-5
RCL
62
-3
DRI
63
3
Financhill
Back

Verve Therapeutics Stock Predictions

Sell
12

VERV
Verve Therapeutics

Last Price:
5.97
Seasonality Move:
80.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Verve Therapeutics Stock Forecast

  • Over the next 52 weeks, Verve Therapeutics has on average historically fallen by 18.4% based on the past 2 years of stock performance.
  • Verve Therapeutics has fallen lower in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Verve Therapeutics Stock Undervalued?
    The current Verve Therapeutics [VERV] share price is $5.98. The Score for VERV is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • VERV is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Verve Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Verve Therapeutics has on average historically fallen by 18.4% based on the past 2 years of stock performance.

Verve Therapeutics Stock Rating

Sell
12
Verve Therapeutics (VERV) is a Sell

Is Verve Therapeutics overpriced?

  • Verve Therapeutics has fallen lower in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Verve Therapeutics Stock Price History

Is VERV stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VERV is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vervetx.com

52-Week Data

52-Week High:
21.42
52-Week Low:
5.84

Prediction Charts

Market Cap:
502.11M
Price in USD:
5.98
Volume:
2.19M
Beta:
1.99

Technical Analysis

SMA50:
9.03
SMA100:
11.15
SMA200:
12.08
52-Wk Change:
-65.11%

Stock Predictions

  • Is Verve Therapeutics stock public?
    Yes, Verve Therapeutics is a publicly traded company.
  • What is the Verve Therapeutics stock quote today?
    The Verve Therapeutics stock price is 5.98 USD today.
  • How to buy Verve Therapeutics stock online?
    You can buy Verve Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-30 6.09 6.02 6.32 5.96
May-1 6.04 5.99 6.56 5.84
May-2 6.13 6.14 6.25 6.00
May-3 6.43 6.41 7.00 6.28
May-6 6.50 6.42 6.73 6.28
May-7 6.46 6.17 6.46 6.04
May-8 6.13 6.08 6.29 5.99
May-9 6.13 6.37 6.73 6.13
May-10 6.32 6.01 6.43 5.88
May-13 6.14 6.22 6.83 6.10
May-14 6.51 6.23 6.83 6.13
May-15 6.47 6.23 6.62 6.12
May-16 6.77 6.38 6.77 6.32
May-17 6.33 5.98 6.34 5.90

Verve Therapeutics Earnings

Verve Therapeutics Earnings Report: Per Share Verve Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Verve Therapeutics Forecast Revenue Growth

Verve Therapeutics Stock Analysis: Historical quarterly revenues per share for Verve Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.22 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.68 per share, and a decrease next year of $0.28 per share.

* Verve Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.